Sodium Fluoride Chewable Tablets

Manufacturer
HTO Nevada Inc. | Medical Products Laboratories | KIRKMAN LABORATORIES INC
Effective date
2019-09-11
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 00:12:34

Label at a glance#

ProductSODIUM FLUORIDE CHERRY
Active ingredientSodium Fluoride
Label structure15 sections

Indications and uses

For once daily, self-administered, systemic use as a dental caries preventive in pediatric patients.  It has been established that ingestion of fluoridated drinking water ( 1 ppm F ) during the period of tooth development results in a significant decrease in the incidence of dental caries.  Kirkman's 2.21 mg Sodium Fluoride Tablets were developed to provide systemic fluoride for use as a supplement in pediatric pa...

Dosage and administration

Follow the direction for using this medication provided by your doctor. Daily Pediatric Dose: Fluoride Content of Drinking Water: Birth to 6 mos. 6 mos. to Age 3 Age 3 to 6 Age 6 to 16 Less than 0.3 ppm 0 1/4 tablet 1/2 tablet 1 tablets 0.3 to 0.6 ppm 0 0 1/4 tablet 1/2 tablet Greater than 0.6 ppm 0 0 0 0

Storage and handling

Store at Controlled Room Temperature, 20-25 °C (68-77 °F).  See USP "Controlled Room" for further information. NDC 58223-679-01 Manufactured for KIRKMAN Laboratories, Inc 17387 SW 63rd Ave. Lake Oswego, OR 97035

Label contents#

Full prescribing information#

DESCRIPTION:

DESCRIPTION SECTION

Kirkman's 2.21 mg (1.0 mg fluoride ion) Sodium Fluoride Tablets are dye free.  Each 2.21 mg (full strength) tablet contains 1.0 mg of the fluoride ion (F) from 2.21 mg sodium fluoride (NaF).  Each tablet for oral administration contain sodium fluoride equivalent to 1.0 mg of the fluoride ion and the following inactive ingredients: Lactose, Cherry Flavor, Saccharin Sodium and Magnesium Stearate.

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Sodium fluoride acts systemically (before tooth eruption ) and topically (post eruption) by increasing tooth resistance to acid dissolution, by promoting remineralization , and by inhibiting the cariogenic microbial process. 

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

For once daily, self-administered, systemic use as a dental caries preventive in pediatric patients.  It has been established that ingestion of fluoridated drinking water ( 1 ppm F ) during the period of tooth development results in a significant decrease in the incidence of dental caries.  Kirkman's 2.21 mg Sodium Fluoride Tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients form 6 months to 16 years of age living in areas where the drinking water fluoride content does not exceed 0.6 ppm (F).

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

Krikman's 2.21 mg Sodium Fluoride Tablets, are contraindicated when the fluoride content of drinking water is 0.6 ppm (F) or more and should not be administered to pediatric patients under the age of 6 months.  Do not administer fluoride (any strength) to pediatric patients under age 6 months.

WARNINGS:

WARNINGS SECTION

Prolonged daily ingestion of quantities greater than the recommended amount may result in various degrees of dental fluorosis in pediatric patients under age 6 years, especially if the water fluoridation exceeds 0.6 ppm.  Read directions carefully before using. 

PRECAUTIONS:

PRECAUTIONS SECTION

General:  Please refer to CONTRAINDICATIONS, WARNINGS, and OVERDOSAGE sections for overdose concerns.  Use in pediatric patients below the age of 6 months is not recommended by current American Dental Association and American Academy of Pediatrics guidelines. 

Drug Interactions:

DRUG INTERACTIONS SECTION

Do not eat or drink dairy products within one hour of fluoride administration.  Incompatibility of fluoride with dairy foods has been reported due to formation of calcium fluoride which is poorly absorbed.

Nursing Mothers:

NURSING MOTHERS SECTION

It is not known if fluoride ion is excreted in human milk.  However, many drugs are excreted in human milk and caution should be exercised when Kirkman's 2.21 mg Sodium Tablets are administered to nursing women.

Pediatric Use:

PEDIATRIC USE SECTION

The use of Kirkman's 2.21 mg Sodium Fluoride Tablets as a caries preventive in pediatric age groups 6 months to 16 years is supported by evidence from adequate and well-controlled studies on fluoride supplementation from birth through adolescence.

Geriatric Use:

GERIATRIC USE SECTION

Not indicated for use in geriatric patients.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Allergic rash and other idiosyncrasies have rarely been reported.  Call your doctor for medical advice about side effects.  You may report side effects tot the FDA at 1-800-FDA-1088.

OVERDOSAGE:

OVERDOSAGE SECTION

Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue.  Nausea, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis, and epigastric cramping abdominal pain.  These symptoms may persist for up to 24 hours.  If less than 5 mg sodium fluoride/kg body weight (i.e. less than 2.3 mg sodium fluoride/lb body weight) has been ingested, induce vomiting, give orally soluble calcium (e.g. milk, 5% calcium gluconate, or calcium lactate solution) and immediately seek medical assistance.  For accidental ingestion of more than 15 mg sodium fluoride/kg of body weight (i.e. more than 6.9 mg sodium fluoride/lb of body weight), induce vomiting and seek emergency medical help.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Follow the direction for using this medication provided by your doctor.

Daily Pediatric Dose:
Fluoride Content of
Drinking Water:
Birth to
6 mos.
6 mos. to
Age 3
Age 3
to 6
Age 6
to 16
Less than 0.3 ppm01/4 tablet1/2 tablet1 tablets
0.3 to 0.6 ppm001/4 tablet1/2 tablet
Greater than 0.6 ppm0000

STORAGE AND HANDLING

STORAGE AND HANDLING SECTION

Store at Controlled Room Temperature, 20-25 °C (68-77 °F).  See USP "Controlled Room" for further information.

NDC 58223-679-01

Manufactured for KIRKMAN Laboratories, Inc
17387 SW 63rd Ave.
Lake Oswego, OR 97035

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

KIRKMAN LABORATORIES, INC.

SODIUM FLUORIDE TABLETS

Dye-free!

Cherry Flavored

Chewable Sodium Fluoride Tablets USP

CAUTION: Federal law prohibits dispensing without prescription

A product of
KIRKMAN LABORATORIES, INC.
Lake Oswego, OR 97035

2.21 mg NaF = 1 mg Fluoride Ion

100 Tablets

NDC 58223-679-01

Each tablet contains 2.21 mg of Sodium Fluoride equivalent to 1 mg of the fluoride ion.

INGREDIENTS: Sodium Fluoride USP, Lactose, Cherry Flavor, Saccharin Sodium, Magnesium Stearate.

Dispense in light resistant, tight container as defined in the USP.
Keep bottle tightly closed.

Keep Out of the Reach of Children.

Manufactured for: Kirkman Laboratories, Inc., Lake Oswego, OR 97035

FL035

Sodium Fluoride Tablets Label
Sodium Fluoride Tablets Label

BERMUDA GOVERNMENT PREVENTIVE DENTAL PROGRAM

For School Use Only

Sodium Fluoride 2.21 MG
(1.0 mg Fluoride)

1000 TABLETS

FOR CLASS DISTRIBUTION ONLY

DAILY DOSE: One tablet per child per day for children ages 6-13.

*KEEP THIS BOTTLE OUT OF REACH OF CHILDREN*

• It is important to keep to the correct dosage.
• Do not give these tablets along with any other tablets that contain fluoride (such as vitamin-fluoride combinations)
• Keep this bottle in a safe, cool place.
• For further information, Tel. (441) 278-6440.
  Senior Dental Office, Dept. of Health
  Victoria Street, Hamilton Bermuda

Each tablet contains 2.21 mg of Sodium Fluoride USP, equivalent to 1.0 mg of the fluoride ion.

INGREDIENTS: Sodium Fluoride USP, Lactose, Cherry Flavor, Saccharin Sodium, Magnesium Stearate.

DYE FREE!

KIRKMAN LABORATORIES INC.
LAKE OSWEGO, OR 97035

LABEL P/N #: FL045
Bulk #: 679-04
Lot #: 00000000
Pkg. Date: 00/00
Exp. Date: 00/00

2.2 mg label
2.2 mg label

BERMUDA GOVERNMENT PREVENTIVE DENTAL PROGRAM

For Individual Use Only

Sodium Fluoride 2.21 MG
(1.0 mg Fluoride)

For Home Treatment (70 Tablets)

Name: ____________________________________
School:________________________ Grade:_____

DAILY DOSE: One tablet per child per day for children ages 6 to 13.

• KEEP OUT OF THE REACH OF CHILDREN.
• It is important to keep to the correct dosage.
• Do not give these tablets along with any other tablets that contain fluoride (such as vitamin-fluoride combinations)
• Keep this bottle in a safe, cool place.
• For further information, Tel. (441) 278-6440
  Senior Dental Office, Dept. of Health
  Victoria Street, Hamilton Bermuda


Each tablet contains 2.21 mg of Sodium Fluoride USP, equivalent to 1.0 mg of the fluoride ion.

INGREDIENTS: Sodium Fluoride USP, Lactose, Cherry Flavor, Saccharin Sodium, Magnesium Stearate.

DYE FREE!

KIRKMAN LABORATORIES INC.
LAKE OSWEGO, OR 97035

LABEL P/N #: FL044
Bulk #: 679-70
Lot #: 00000000
Pkg. Date: 00/00
Exp. Date: 00/00

 

2.2 mg label
2.2 mg label

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
58223-679-01EA - Each58223-6799396bb81-2be1-4014-95a8-0fcf4f8ea2ec12014-04-03
58223-679-04EA - Each58223-679992e4462-d3bf-494f-8dca-f6045a58d34e12018-03-08

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Sodium FluorideACTIVE INGREDIENT8ZYQ1474W71
Fluoride IonACTIVE MOIETYQ80VPU408O1
LactoseINACTIVE INGREDIENTJ2B2A4N98G1
Magnesium StearateINACTIVE INGREDIENT70097M6I301
Saccharin SodiumINACTIVE INGREDIENTSB8ZUX40TY1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
58223-67958223-679-01, 58223-679-04, 58223-679-70, 58223-679-09

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 109 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYELIXIR / ORAL15 mg/5mlExact identifier — unii candidate
34 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
36 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYTABLET / ORAL43 mgExact identifier — unii candidate
34 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYTABLET, FOR SUSPENSION / ORAL6 mgExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE, EXTENDED RELEASE / ORAL9 mgExact identifier — unii candidate
39 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GGRANULE, FOR SUSPENSION / ORAL512.5 mg/5mlExact identifier — unii candidate
36 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYFILM, SOLUBLE / BUCCAL2 mgExact identifier — unii candidate
34 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS133 mgExact identifier — unii candidate
36 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYTABLET / BUCCAL0.4 mgExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30CAPSULE / ORAL256.4 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET / BUCCAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30SYSTEM / INTRAVITREAL0.02 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30POWDER, FOR SUSPENSION / ORAL120 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYPOWDER, FOR SOLUTION / ORAL199 mgExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30LOZENGE / ORAL420 mgExact identifier — unii candidate
39 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GINJECTION, SOLUTION / INTRAVENOUS0.45 %w/vExact identifier — unii candidate
36 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30SUSPENSION, EXTENDED RELEASE / ORAL71 mgExact identifier — unii candidate
39 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GTABLET, CHEWABLE / ORAL1412 mgExact identifier — unii candidate
36 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30RING / VAGINAL2 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30POWDER / ORAL25 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30GRANULE, FOR SUSPENSION / ORAL14 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, FOR SUSPENSION / ORAL131 mgExact identifier — unii candidate
39 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GTABLET / BUCCAL296.7 mgExact identifier — unii candidate
36 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYPOWDER, FOR SUSPENSION / ORAL85 mgExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, DELAYED RELEASE / ORAL144 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30INHALANT / ORAL0.08 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL47 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30POWDER / TOPICAL104 mgExact identifier — unii candidate
39 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYCONCENTRATE / ORAL6 mgExact identifier — unii candidate
34 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GCONCENTRATE / ORALNAExact identifier — unii candidate
36 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYSUSPENSION / ORAL5000 mg/5mlExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30LOZENGE / TRANSMUCOSAL100 mgExact identifier — unii candidate
39 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GPOWDER, FOR SOLUTION / ORALNAExact identifier — unii candidate
36 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GTABLET / SUBLINGUAL352 mgExact identifier — unii candidate
36 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30GRANULE / ORAL629 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, FILM COATED, EXTENDED RELEASE / ORAL53 mgExact identifier — unii candidate
39 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GCAPSULE, DELAYED RELEASE / ORAL231.84 mgExact identifier — unii candidate
36 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYINJECTION / INTRAVENOUS22 mgExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TROCHE / ORAL315 mgExact identifier — unii candidate
39 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30IMPLANT / INTRAVITREALNAExact identifier — unii candidate
39 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GINJECTION / INTRAMUSCULAR203.5 mgExact identifier — unii candidate
36 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GTABLET, FILM COATED, EXTENDED RELEASE / ORAL620 mgExact identifier — unii candidate
36 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GOINTMENT / TOPICALNAExact identifier — unii candidate
36 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYSYRUP / ORAL24 mgExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30CAPSULE, EXTENDED RELEASE / ORAL117 mgExact identifier — unii candidate
39 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYSOLUTION / DENTAL0.05 %w/vExact identifier — unii candidate
34 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY193.8 mgExact identifier — unii candidate
36 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30DROPS / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYCAPSULE / ORAL24 mgExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE / ORAL127 mgExact identifier — unii candidate
39 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYINJECTION / INTRAMUSCULAR22 mgExact identifier — unii candidate
34 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, COATED / ORAL184 mgExact identifier — unii candidate
39 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYPASTE / ORAL3 mgExact identifier — unii candidate
34 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GSUPPOSITORY / VAGINALNAExact identifier — unii candidate
36 equally ranked IID candidates
LactoseLACTOSEJ2B2A4N98GINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS133 mgExact identifier — unii candidate
36 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
Saccharin SodiumSACCHARIN SODIUMSB8ZUX40TYSOLUTION / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
34 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f709b5f8-7cec-448d-bf1f-5afd94aa634aac5896fa-0d33-7132-e63e-37786e914f122020-12-07Warnings, Adverse reactionsExact identifier
spl set id: ac5896fa-0d33-7132-e63e-37786e914f12

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.